Hostname: page-component-78c5997874-lj6df Total loading time: 0 Render date: 2024-11-03T01:42:59.907Z Has data issue: false hasContentIssue false
  • English
  • Français

BDNF and NRG1 polymorphisms and temperament in selective serotonin reuptake inhibitor-treated patients with major depression

Published online by Cambridge University Press:  09 January 2018

Kadri Andre ,
Olli Kampman ,
Merja Viikki ,
Eija Setälä-Soikkeli ,
Ari Illi ,
Nina Mononen ,
Terho Lehtimäki  and
Esa Leinonen
Kadri Andre*
Affiliation:
Faculty of Medicine and Life Sciences, University of Tampere, Tampere, Finland
Olli Kampman
Affiliation:
Faculty of Medicine and Life Sciences, University of Tampere, Tampere, Finland Department of Psychiatry, Seinäjoki Hospital District, Seinäjoki, Finland
Merja Viikki
Affiliation:
Faculty of Medicine and Life Sciences, University of Tampere, Tampere, Finland Tampere City Mental Health Care Center, Tampere, Finland
Eija Setälä-Soikkeli
Affiliation:
Department of Psychiatry, Kanta-Häme Hospital District, Hämeenlinna, Finland
Ari Illi
Affiliation:
Faculty of Medicine and Life Sciences, University of Tampere, Tampere, Finland
Nina Mononen
Affiliation:
Faculty of Medicine and Life Sciences, University of Tampere, Tampere, Finland Fimlab Laboratories, Tampere, Finland
Terho Lehtimäki
Affiliation:
Faculty of Medicine and Life Sciences, University of Tampere, Tampere, Finland Fimlab Laboratories, Tampere, Finland
Esa Leinonen
Affiliation:
Faculty of Medicine and Life Sciences, University of Tampere, Tampere, Finland Department of Psychiatry, Tampere University Hospital, Tampere, Finland
*
Kadri Andre, Selkäsuonkatu 11 E 6, Hämeenlinna 13100, Finland. Tel: +358440545954; E-mail: [email protected]
Get access Rights & Permissions [Opens in a new window]

Abstract

Objective

We investigated the separate effects of and possible interactions between the functional polymorphisms of brain-derived neurotrophic factor (BDNF) rs11030101, BDNF rs61888800, and neuregulin-1 (NRG1) rs3924999 and NRG1 rs6994992 on change of temperament scores in a clinical sample of subjects with major depression (MDD), who received selective serotonin reuptake inhibitor treatment for a period of 6 weeks.

Methods

The study population consisted of 98 Finnish individuals with MDD. They were assessed by the 107-item Temperament and Character Inventory temperament questionnaire (version IX) and the Montgomery–Åsberg Depression Rating Scale (MADRS). In general linear univariate models (GLM) for novelty seeking (NS) or reward dependence (RD) change age, gender, MADRS score change and BDNF and NRG1 genotypes were used as explaining explanatory variables.

Results

Mean comparisons between corresponding temperament dimensions and genotypes showed significant differences between NS change and BDNF rs61888800 T-carrying status (mean difference: GG 0.30, GT/TT 2.47, p=0.022, t-test) and between RD change and NRG1 rs3924999 A-carrying status (mean difference: GG 1.21, GA/AA −0.33, p=0.003). In GLM models for NS change the significant predictors comprised BDNF rs61888800 T-carrying status, age and MADRS score change (model 1), and additionally NRG1 rs6994992 T-carrying status (model 2). For RD change the predictors included NRG1 rs3924999 A-carrying status, age and MADRS score change (model 1) and additionally gender (model 2).

Conclusion

According to the current results both BDNF and NRG1 are associated with temperament traits during depression. These results warrant further studies regarding the impact of this association on depression recovery.

Keywords

brain-derived neurotrophic factordepressionneuregulin-1temperament
Type
Original Article
Information
Acta Neuropsychiatrica , Volume 30 , Issue 3 , June 2018 , pp. 168 - 174
Copyright
© Scandinavian College of Neuropsychopharmacology 2018 

Access options

Get access to the full version of this content by using one of the access options below. (Log in options will check for institutional or personal access. Content may require purchase if you do not have access.)

References

1. Schwartz, CE, Kunwar, PS, Greve, DN et al. Structural differences in adult orbital and ventromedial prefrontal cortex predicted by infant temperament at 4 months of age. Arch Gen Psychiatry 2010;67:78–84.Google Scholar
2. Post, RM. Role of BDNF in bipolar and unipolar disorder: clinical and theoretical implications. J Psychiatr Res 2007;41:979–990.Google Scholar
3. Kazantseva, A, Gaysina, D, Kutlumbetova, Y et al. Brain derived neurotrophic factor gene (BDNF) and personality traits: the modifying effect of season of birth and sex. Prog Neuropsychopharmacol Biol Psychiatry 2015;56:58–65.Google Scholar
4. Maletic, V, Robinson, M, Oakes, T, Iyengar, S, Ball, SG, Russell, J. Neurobiology of depression: an integrated view of key findings. Int J Clin Pract 2007;61:2030–2040.Google Scholar
5. Biernacka, JM, Sangkuhl, K, Jenkins, G et al. The International SSRI Pharmacogenomics Consortium (ISPC): a genome-wide association study of antidepressant treatment response. Transl Psychiatry 2015;5:e553.Google Scholar
6. Wen, Z, Chen, J, Khan, RA et al. Genetic association between NRG1 and schizophrenia, major depressive disorder, bipolar disorder in Han Chinese population. Am J Med Genet B Neuropsychiatr Genet 2016;171B:468–478.Google Scholar
7. Castren, E, Rantamaki, T. The role of BDNF and its receptors in depression and antidepressant drug action: reactivation of developmental plasticity. Dev Neurobiol 2010;70:289–297.Google Scholar
8. Lundgaard, I, Luzhynskaya, A, Stockley, JH et al. Neuregulin and BDNF induce a switch to NMDA receptor-dependent myelination by oligodendrocytes. PLoS Biol 2013;11:e1001743.Google Scholar
9. Cloninger, CR, Svrakic, DM, Przybeck, TR. A psychobiological model of temperament and character. Arch Gen Psychiatry 1993;50:975–990.Google Scholar
10. Cloninger, CR. A unified biosocial theory of personality and its role in the development of anxiety states. Psychiatr Dev 1986;4:167–226.Google Scholar
11. Zaninotto, L, Solmi, M, Toffanin, T, Veronese, N, Cloninger, CR, Correll, CU. A meta-analysis of temperament and character dimensions in patients with mood disorders: comparison to healthy controls and unaffected siblings. J Affect Disord 2016;194:84–97.Google Scholar
12. Miettunen, J, Raevuori, A. A meta-analysis of temperament in axis I psychiatric disorders. Compr Psychiatry 2012;53:152–166.Google Scholar
13. Kampman, O, Poutanen, O. Can onset and recovery in depression be predicted by temperament? A systematic review and meta-analysis. J Affect Disord 2011;135:20–27.Google Scholar
14. Josefsson, K, Merjonen, P, Jokela, M, Pulkki-Raback, L, Keltikangas-Jarvinen, L. Personality profiles identify depressive symptoms over ten years? A population-based study. Depress Res Treat 2011;2011:431314.Google Scholar
15. Kitamura, T, Cloninger, CR. Temperament and character domains of personality and depression. Depress Res Treat 2011;2011:765691.Google Scholar
16. Nery, FG, Hatch, JP, Nicoletti, MA et al. Temperament and character traits in major depressive disorder: influence of mood state and recurrence of episodes. Depress Anxiety 2009;26:382–388.Google Scholar
17. Quilty, LC, Godfrey, KM, Kennedy, SH, Bagby, RM. Harm avoidance as a mediator of treatment response to antidepressant treatment of patients with major depression. Psychother Psychosom 2010;79:116–122.Google Scholar
18. Jylha, PJ, Rosenstrom, T, Mantere, O et al. Temperament, character, and suicide attempts in unipolar and bipolar mood disorders. J Clin Psychiatry 2016;77:252–260.Google Scholar
19. Hruby, R, Nosalova, G, Ondrejka, I, Preiss, M. Personality changes during antidepressant treatment. Psychiatr Danub 2009;21:25–32.Google Scholar
20. Teraishi, T, Hori, H, Sasayama, D et al. Personality in remitted major depressive disorder with single and recurrent episodes assessed with the Temperament and Character Inventory. Psychiatry Clin Neurosci 2015;69:3–11.Google Scholar
21. Licinio, J, Dong, C, Wong, ML. Novel sequence variations in the brain-derived neurotrophic factor gene and association with major depression and antidepressant treatment response. Arch Gen Psychiatry 2009;66:488–497.Google Scholar
22. Castren, E, Kojima, M. Brain-derived neurotrophic factor in mood disorders and antidepressant treatments. Neurobiol Dis 2017;97(Pt B):119–126.Google Scholar
23. Illi, A, Viikki, M, Poutanen, O et al. No support for a role for BDNF gene polymorphisms rs11030101 and rs61888800 in major depressive disorder or antidepressant response in patients of Finnish origin. Psychiatr Genet 2013;23:33–35.Google Scholar
24. Pae, CU, Chiesa, A, Porcelli, S et al. Influence of BDNF variants on diagnosis and response to treatment in patients with major depression, bipolar disorder and schizophrenia. Neuropsychobiology 2012;65:1–11.Google Scholar
25. Viikki, ML, Jarventausta, K, Leinonen, E et al. BDNF polymorphism rs11030101 is associated with the efficacy of electroconvulsive therapy in treatment-resistant depression. Psychiatr Genet 2013;23:134–136.Google Scholar
26. Colle, R, Deflesselle, E, Martin, S et al. BDNF/TRKB/P75NTR polymorphisms and their consequences on antidepressant efficacy in depressed patients. Pharmacogenomics 2015;16:997–1013.Google Scholar
27. Mei, L, Xiong, WC. Neuregulin 1 in neural development, synaptic plasticity and schizophrenia. Nat Rev Neurosci 2008;9:437–452.Google Scholar
28. Bousman, CA, Potiriadis, M, Everall, IP, Gunn, JM. Effects of neuregulin-1 genetic variation and depression symptom severity on longitudinal patterns of psychotic symptoms in primary care attendees. Am J Med Genet B Neuropsychiatr Genet 2014;165B:62–67.Google Scholar
29. Vaht, M, Laas, K, Kiive, E, Parik, J, Veidebaum, T, Harro, J. A functional neuregulin-1 gene variant and stressful life events: effect on drug use in a longitudinal population-representative cohort study. J Psychopharmacol. 2017;31:54–61.Google Scholar
30. Mandelli, L, Mazza, M, Martinotti, G et al. Further evidence supporting the influence of brain-derived neurotrophic factor on the outcome of bipolar depression: independent effect of brain-derived neurotrophic factor and harm avoidance. J Psychopharmacol 2010;24:1747–1754.Google Scholar
31. Montgomery, SA, Asberg, M. A new depression scale designed to be sensitive to change. Br J Psychiatry 1979;134:382–389.Google Scholar
32. Kim, SJ, Cho, SJ, Jang, HM et al. Interaction between brain-derived neurotrophic factor Val66Met polymorphism and recent negative stressor in harm avoidance. Neuropsychobiology 2010;61:19–26.Google Scholar
33. Minelli, A, Zanardini, R, Bonvicini, C et al. BDNF serum levels, but not BDNF Val66Met genotype, are correlated with personality traits in healthy subjects. Eur Arch Psychiatry Clin Neurosci 2011;261:323–329.Google Scholar
34. Montag, C, Basten, U, Stelzel, C, Fiebach, CJ, Reuter, M. The BDNF Val66Met polymorphism and anxiety: support for animal knock-in studies from a genetic association study in humans. Psychiatry Res 2010;179:86–90.Google Scholar
35. Hunnerkopf, R, Strobel, A, Gutknecht, L, Brocke, B, Lesch, KP. Interaction between BDNF Val66Met and dopamine transporter gene variation influences anxiety-related traits. Neuropsychopharmacology 2007;32:2552–2560.Google Scholar
36. Frustaci, A, Pozzi, G, Gianfagna, F, Manzoli, L, Boccia, S. Meta-analysis of the brain-derived neurotrophic factor gene (BDNF) Val66Met polymorphism in anxiety disorders and anxiety-related personality traits. Neuropsychobiology 2008;58:163–170.Google Scholar
37. Grucza, RA, Przybeck, TR, Cloninger, CR. Personality as a mediator of demographic risk factors for suicide attempts in a community sample. Compr Psychiatry 2005;46:214–222.Google Scholar
38. Shamir, A, Kwon, OB, Karavanova, I et al. The importance of the NRG-1/ErbB4 pathway for synaptic plasticity and behaviors associated with psychiatric disorders. J Neurosci 2012;32:2988–2997.Google Scholar
39. Nemes, B, Cozman, D. The relevance of personality assessment in estimating the risk of onset and the outcome of major depressive disorder. Clujul Med 2016;89:212–215.Google Scholar
40. Brandstrom, S, Richter, J, Przybeck, T. Distributions by age and sex of the dimensions of temperament and character inventory in a cross-cultural perspective among Sweden, Germany, and the USA. Psychol Rep 2001;89:747–758.Google Scholar
41. Braineac, the UK Brain Expression Consortium database. Available at http://www.braineac.org/. Accessed November 11, 2016.Google Scholar
42. Gutiérrez, B, Bellón, JÁ, Rivera, M et al. The risk for major depression conferred by childhood maltreatment is multiplied by BDNF and SERT genetic vulnerability: a replication study. J Psychiatry Neurosci 2015;40:187–196.Google Scholar
43. Andre, K, Kampman, O, Illi, A et al. SERT and NET polymorphisms, temperament and antidepressant response. Nord J Psychiatry 2015;69:531–538.Google Scholar
44. Sadock, BJ, Sadock, VA, Ruiz, P. Kaplan & Sadock’s synopsis of psychiatry. Behavioral sciences/clinical psychiatry, 11th edition. Philadelphia: Wolters Kluwer, 2015.Google Scholar